Sign in
CDXC Stock Price, Chart, Stats & News
ChromaDex Corporation
Save
ChromaDex Corporation (CDXC) does not currently pay a dividend.
611.90M
Market cap
71.55x
Current P/E
–
Forward P/E
CDXC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 272.92% |
Operating margin | 53.41% |
Pretax margin | 59.68% |
Net margin | 57.03% |
Effective tax rate | 4.45% |
ROA | 16.34% |
ROE | 26.06% |
D/E | 0.04x |
Interest coverage ratio | – |
CDXC valuation
P/E | 71.55x |
P/S | 20.07x |
P/B | 8.12x |
P/CF | 14.34x |
P/FCF | 14.34x |
P/OCF | 14.34x |
PEG | -2.41x |
EV multiple | 38.71x |
About
ChromaDex Corporation is a bioscience enterprise committed to advancing healthy aging. The company's operations are segmented into three primary areas: Consumer Products, Ingredients, and Analytical Reference Standards and Services. Its research efforts largely concentrate on nicotinamide adenine dinucleotide (NAD+).
Similar securities
Based on sector and market capitalization
Report issue